What the FDA labels say about taking them together
Docetaxel and paclitaxel
Docetaxel's FDA label of July 15, 2025 names paclitaxel in its warnings and precautions section; the paclitaxel labels PlainMeds reads (4) do not name docetaxel.
Check it at the source: the docetaxel FDA label on DailyMed (effective July 15, 2025, Avyxa Pharma, LLC); the paclitaxel FDA label on DailyMed (effective January 21, 2026, Natco Pharma USA LLC).
What does the docetaxel label say about paclitaxel?
Docetaxel label, warnings and precautionsPatients who have previously experienced a hypersensitivity reaction to paclitaxel may develop a hypersensitivity reaction to docetaxel that may include severe or fatal reactions such as anaphylaxis.
Source: FDA drug label (DOCIVYX), Avyxa Pharma, LLC, effective July 15, 2025 (SPL set 4763744e-360e-4d37-be05-cce4114548cd), via openFDA; the full label on DailyMed
What does the paclitaxel label say about docetaxel?
Paclitaxel's label (effective January 21, 2026) and its 3 other brand-application labels do not name docetaxel in these sections. A label lists what its studies and reports found; it is not a complete list.
Source: FDA drug label (Paclitaxel), Natco Pharma USA LLC, effective January 21, 2026 (SPL set a1eb16b4-285b-4e81-9c4e-1244d4a52af8), via openFDA; the full label on DailyMed
These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.
Both medicines on the record
| Docetaxel | Paclitaxel | |
|---|---|---|
| Labeled for | Breast cancer, Lung cancer, Prostate cancer | Breast cancer, Lung cancer |
| Boxed warning | Yes | Yes |
| Pharmacy cost (NADAC) | n/a | n/a |
| Shortage now | A presentation being discontinued | No current entry |
Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)
What next?
- Check more medicines together
- up to five at once